Cargando…
Endogenous annexin A1 is a novel protective determinant in nonalcoholic steatohepatitis in mice
Annexin A1 (AnxA1) is an effector of the resolution of inflammation and is highly effective in terminating acute inflammatory responses. However, its role in chronic settings is less investigated. Because changes in AnxA1 expression within adipose tissue characterize obesity in mice and humans, we q...
Autores principales: | Locatelli, Irene, Sutti, Salvatore, Jindal, Aastha, Vacchiano, Marco, Bozzola, Cristina, Reutelingsperger, Chris, Kusters, Dennis, Bena, Stefania, Parola, Maurizio, Paternostro, Claudia, Bugianesi, Elisabetta, McArthur, Simon, Albano, Emanuele, Perretti, Mauro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4258084/ https://www.ncbi.nlm.nih.gov/pubmed/24668763 http://dx.doi.org/10.1002/hep.27141 |
Ejemplares similares
-
Effect of Colesevelam on Liver Fat Quantified by Magnetic Resonance in Nonalcoholic Steatohepatitis: A Randomized Controlled Trial
por: Le, Thuy-Anh, et al.
Publicado: (2012) -
Ezetimibe for the Treatment of Nonalcoholic Steatohepatitis: Assessment by Novel Magnetic Resonance Imaging and Magnetic Resonance Elastography in a Randomized Trial (MOZART Trial)
por: Loomba, Rohit, et al.
Publicado: (2015) -
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
por: Younossi, Zobair M., et al.
Publicado: (2023) -
Lipid zonation and phospholipid remodeling in nonalcoholic fatty liver disease
por: Hall, Zoe, et al.
Publicado: (2017) -
IL-17 Signaling Accelerates the Progression of Nonalcoholic Fatty Liver Disease in Mice
por: Harley, Isaac TW, et al.
Publicado: (2014)